Rochester, MN, United States of America

Chung Ii Wi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chung Ii Wi. Retrieved from https://idiyas.com/inventor/chung-ii-wi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Chung Ii Wi in Medical Treatment

Introduction

Chung Ii Wi is an accomplished inventor based in Rochester, MN (US). He has made significant contributions to the field of medical treatment, particularly in the area of anti-type 2 therapy. His work focuses on developing methods and materials for treating various medical conditions.

Latest Patents

Chung Ii Wi holds 1 patent for his innovative work titled "Methods for treating medical conditions by anti-type 2 therapy." This patent outlines methods and materials involved in treating medical conditions, specifically targeting asthma in mammals with a Th2 immune response. The patent details the use of anti-Interleukin 4, anti-Interleukin 5, and/or anti-Interleukin 13 antibodies, utilizing a whole blood cell-based cytokine assay.

Career Highlights

Chung Ii Wi is affiliated with the Mayo Foundation for Medical Education and Research, where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of asthma and other related medical conditions.

Collaborations

Chung has collaborated with notable colleagues, including Young J Juhn and Hirohito Kita, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Chung Ii Wi's contributions to medical treatment through his patent on anti-type 2 therapy exemplify the importance of innovation in healthcare. His work not only enhances our understanding of asthma treatment but also paves the way for future advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…